VU-0238429: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:VU-0238429}} | |||
'''VU-0238429''' is a chemical compound that acts as a selective positive allosteric modulator of the [[ | == Overview == | ||
[[File:VU0238429_structure.png|thumb|right|Chemical structure of VU-0238429]] | |||
'''VU-0238429''' is a chemical compound that acts as a selective positive allosteric modulator of the [[metabotropic glutamate receptor]] subtype 4 (mGluR4). It is used primarily in scientific research to study the role of mGluR4 in the central nervous system and its potential therapeutic applications. | |||
== Chemical | == Chemical Properties == | ||
VU-0238429 is characterized by its specific chemical structure, which allows it to selectively modulate the activity of mGluR4. The compound's structure is depicted in the image to the right, highlighting its unique molecular configuration. | |||
== Mechanism of Action == | == Mechanism of Action == | ||
VU-0238429 functions as a positive allosteric modulator, meaning it binds to a site on the mGluR4 receptor that is distinct from the orthosteric site where the endogenous ligand, [[glutamate]], binds. This binding enhances the receptor's response to glutamate, thereby modulating neurotransmission in the brain. | |||
VU-0238429 functions as a positive allosteric modulator, meaning it binds to a site on the | |||
== Research Applications == | == Research Applications == | ||
Research involving VU-0238429 has focused on its potential therapeutic benefits in neurological disorders. By modulating mGluR4 activity, VU-0238429 may influence pathways involved in [[Parkinson's disease]], [[anxiety disorders]], and [[schizophrenia]]. | |||
== Pharmacological Effects == | |||
Studies have shown that VU-0238429 can produce anxiolytic and antipsychotic-like effects in animal models. These effects are attributed to its ability to enhance mGluR4-mediated neurotransmission, which may help in balancing excitatory and inhibitory signals in the brain. | |||
== | == Safety and Toxicology == | ||
As with many research chemicals, the safety profile of VU-0238429 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. | |||
VU-0238429 is | |||
== Related Pages == | == Related Pages == | ||
* [[Metabotropic glutamate receptor]] | |||
* [[ | |||
* [[Allosteric modulator]] | * [[Allosteric modulator]] | ||
* [[ | * [[Neurotransmission]] | ||
* [[Parkinson's disease]] | * [[Parkinson's disease]] | ||
[[Category: | [[Category:Chemical compounds]] | ||
[[Category:Research | [[Category:Pharmacology]] | ||
[[Category:Research tools]] | |||
Latest revision as of 10:59, 15 February 2025
Overview[edit]
VU-0238429 is a chemical compound that acts as a selective positive allosteric modulator of the metabotropic glutamate receptor subtype 4 (mGluR4). It is used primarily in scientific research to study the role of mGluR4 in the central nervous system and its potential therapeutic applications.
Chemical Properties[edit]
VU-0238429 is characterized by its specific chemical structure, which allows it to selectively modulate the activity of mGluR4. The compound's structure is depicted in the image to the right, highlighting its unique molecular configuration.
Mechanism of Action[edit]
VU-0238429 functions as a positive allosteric modulator, meaning it binds to a site on the mGluR4 receptor that is distinct from the orthosteric site where the endogenous ligand, glutamate, binds. This binding enhances the receptor's response to glutamate, thereby modulating neurotransmission in the brain.
Research Applications[edit]
Research involving VU-0238429 has focused on its potential therapeutic benefits in neurological disorders. By modulating mGluR4 activity, VU-0238429 may influence pathways involved in Parkinson's disease, anxiety disorders, and schizophrenia.
Pharmacological Effects[edit]
Studies have shown that VU-0238429 can produce anxiolytic and antipsychotic-like effects in animal models. These effects are attributed to its ability to enhance mGluR4-mediated neurotransmission, which may help in balancing excitatory and inhibitory signals in the brain.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of VU-0238429 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented.
